Correction to: Drugs & Therapy Perspectives (2018) 34(10):451--456 10.1007/s40267-018-0551-x {#Sec1}
============================================================================================

The article Fostamatinib in chronic immune thrombocytopenia: a profile of its use in the USA, was originally published Online First without open access. After publication in volume 34, issue 10, pages 451--456, Rigel Pharmaceuticals, Inc. requested that the article be Open Choice to make the article an open access publication. Post-publication open access was funded by Rigel Pharmaceuticals, Inc. The article is forthwith distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (<http://creativecommons.org/licenses/by-nc/4.0/>), which permits any noncommercial use, duplication, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license and indicate if changes were made.

The original article has been corrected.
